Your session is about to expire
← Back to Search
Prevention Interventions for Substance Use Disorder in Justice-Involved Youth (POST Trial)
POST Trial Summary
This trial is studying three different ways to prevent people in the juvenile justice system from developing problems with opioids.
POST Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPOST Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.POST Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have severe mental health or learning issues that prevent me from participating.I am between 15 and 25 years old.
- Group 1: Enhanced A-CRA (E-ACRA)
- Group 2: Assertive Community Support (ACS)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who would be an ideal candidate for this type of research?
"The requirements to join this study are a history of recidivism and being between 15-25 years old. Up to 215 individuals will be allowed in the study."
Are new enrollees still being sought for this experiment?
"That is correct. The clinical trial, which was first posted on 1/20/2021, is currently recruiting patients and looking for 215 participants across 1 location."
Does this research include any participants who are not yet adults?
"This particular clinical trial is open to patients who are between 15 and 25 years old."
What goals does this research aim to achieve?
"The main goal of this study, which will be measured at the 6 month mark post-release, is to determine the Rate of Recidivism. Other things that will be looked at include Problematic substance use (which refers to Self-reported substance use beyond a developmentally appropriate threshhold), Number of new opioid users (or those who ever used opioids among those who had never used at baseline), and Number of instances of overdose among non-opioid users."
Share this study with friends
Copy Link
Messenger